XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.
Q
Q

QIEN


Yangiliklar

Qiagen Announces Successful Placement Of New Net Share Settled Convertible Bonds

BRIEF-Qiagen Announces Successful Placement Of New Net Share Settled Convertible Bonds Sept 3 (Reuters) - QIAGEN NV QIA.DE : ANNOUNCES SUCCESSFUL PLACEMENT OF NEW NET SHARE SETTLED CONVERTIBLE BONDS REFERENCE SHARE PRICE WILL BE EQUAL TO VOLUME WEIGHTED AVERAGE PRICE OF SHARES ON NEW YORK STOCK EXCHANGE TODAY, SEPTEMBER 3, 2024 INITIAL CONVERSION P
Q

Qiagen Launches Non-Us Offering Of Net Share Settled Convertible Bonds

BRIEF-Qiagen Launches Non-Us Offering Of Net Share Settled Convertible Bonds Sept 3 (Reuters) - QIAGEN NV QIA.DE : LAUNCHES NON-US OFFERING OF NET SHARE SETTLED CONVERTIBLE BONDS COMPANY INTENDS TO ISSUE BONDS IN MINIMUM DENOMINATIONS OF USD 200,000 EACH, IN AN AGGREGATE VOLUME OF USD 450 MILLION HAVE RESOLVED TODAY TO ISSUE SENIOR, UNSECURED NET SHARE SETTLED CONVERTIBLE BONDS, WHICH MAY BE CONVERTED IN PART INTO ORDINARY SHARES OF COMPANY ("SHARES"), DUE 2031 ( " BONDS").
Q

Admiral Group, IAG, Keller Group

EUROPE RESEARCH ROUNDUP- Admiral Group, IAG, Keller Group Aug 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Admiral Group, IAG and Keller Group, on Wednesday. HIGHLIGHTS * Admiral Group Plc ADML.L : HSBC raises target price to 2700p from 2625p * IAG ICAG.L : Citigroup raises target price to 245p from 225p * Keller Group Plc KLR.L : Deutsche Bank raises target price to 1800p from 1550p * OCI NV OCI.AS : JP Morgan raises to overw
A
A
A
B
B
B
B
G
H
I
K
L
M
R
R
S
T
V
Q
M
R

Qiagen NV reports results for the quarter ended in June - Earnings Summary

Qiagen NV reports results for the quarter ended in June - Earnings Summary Qiagen NV QGEN.N reported quarterly adjusted earnings of 55 cents​​ per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of 53 cents. The mean expectation of fourteen analysts for the quarter was for earnings of 51 cents per share.
Q

Qiagen Says FY Net Sales Are Expected To Be At Least $1.985 Billion CER

BRIEF-Qiagen Says FY Net Sales Are Expected To Be At Least $1.985 Billion CER July 31 (Reuters) - Qiagen NV QIA.DE : QIAGEN DELIVERS SOLID PERFORMANCE AND EXCEEDS OUTLOOK FOR Q2 2024 NET SALES WERE STABLE AT $496 MILLION IN Q2 2024 COMPARED TO Q2 2023 : HAS UPDATED ITS FY 2024 OUTLOOK FY OUTLOOK FOR ADJUSTED DILUTED EPS HAS BEEN INCREASED TO AT LEA
Q

Qiagen NV <QGEN.N> expected to post earnings of 51 cents a share - Earnings Preview

Qiagen NV expected to post earnings of 51 cents a share - Earnings Preview Qiagen NV QGEN.N , QGEN.K is expected to show a fall in quarterly revenue when it reports results on July 31 for the period ending June 30 2024 The Venlo Limburg-based company is expected to report a 0.1% decrease in revenue to $494.489 million from $494.86 million a year ago, according to the mean estimate from 13 analysts, based on LSEG data.
Q

Germany corporate earnings week ahead

DIARY-Germany corporate earnings week ahead July 26 (Reuters) - Diary of Germany (.GDAXI) corporate earnings for the week ahead GERMANY EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 30-Jul-2024 NTS 1COV.DE Covestro AG Half Year 2024 Covestro AG Earnings Release 30-Jul-2024 BMO HEIG.DE Heidelberg Materials AG Half Year 2024 Heidelberg Materials AG Earnings Release 30-Jul-2024 04:30 AIR.PA Airbus SE Half Year 2024 Airbus SE Earnings Release 31-Jul-2024 AMC QGEN.N Qiagen NV Q2 20
A
A
B
F
M
P
S
S
V
V
Q
G

Qiagen NV Sees At Least $2 Billion Of Combined Annual Sales In 2028

BRIEF-Qiagen NV Sees At Least $2 Billion Of Combined Annual Sales In 2028 June 17 (Reuters) - Qiagen NV QIA.DE : QIAGEN NV - NEW 2028 TARGETS INCLUDES PLANS TO RETURN AT LEAST $1 BILLION TO SHAREHOLDERS FROM 2024-2028 QIAGEN NV SEES ABOUT 7% COMPOUND ANNUAL SALES GROWTH AT CONSTANT EXCHANGE RATES THROUGH 2024-2028 QIAGEN NV - HAS SET A GOAL FOR AT
Q

Qiagen eyes sales growth of 7% per year until 2028

Qiagen eyes sales growth of 7% per year until 2028 FRANKFURT, June 17 (Reuters) - Diagnostics company Qiagen QIA.DE said on Monday it was targeting 7% currency-adjusted sales growth per year until 2028 on lab testing machines for infections and cancer, as it maps out its post-pandemic strategy. Holding an investor event on Monday, it also issued a goal for adjusted operating income margin of at least 31% in 2028, up from 26.9% in 2023, by winding down unprofitable products and simplifying the or
Q

Evotec and Qiagen enter software collaboration for insights into multi-omics data

BRIEF-Evotec and Qiagen enter software collaboration for insights into multi-omics data June 3 (Reuters) - EVOTEC SE EVTG.DE : EVOTEC AND QIAGEN ENTER SOFTWARE COLLABORATION FOR BETTER INSIGHT INTO MULTI-OMICS DATA Further company coverage: EVTG.DE (Gdansk Newsroom)
Q



Shartlar

Ommabop aktivlar

Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.

Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi

Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.

Riskdan ogohlantirish: Kapitalingiz risk ostida. Kredit yordamiga ega mahsulotlar hammaga ham toʻgʻri kelmasligi mumkin. Bizning Risklardan ogohlantirishimiz bilan tanishib chiqing.